Cost effectiveness data form a crucial part of the debate surrounding the integration of complementary treatments into the NHS.To our knowledge, studies of the cost effectiveness of complementary therapies in the United Kingdom have not previously been reviewed.
No takes yet. Share an insight, caveat, or question.
Canter et al. (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: